Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOME-LITE
NCT00203658Phase 4Completed
- Sponsor
- University of Calgary
- Start
- Apr 1997
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of tinzaparin in venous thrombosis (2 arms), sponsored by University of Calgary. Primary endpoints: Recurrent Venous Thromboembolism at 12 weeks, Death at 12 weeks and 1 more. Started Apr 1997; status: completed.
02
Drugs
tinzaparin
03
Conditions
venous thrombosis
Beyond the preview
Go deeper on NCT00203658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203658.